Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.0877
-0.0093 (-9.59%)
At close: Mar 19, 2026, 4:00 PM EDT
0.0880
+0.0003 (0.34%)
After-hours: Mar 19, 2026, 7:59 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $4.88 million as of March 19, 2026. Its market cap has decreased by -92.45% in one year.
Market Cap
4.88M
Enterprise Value
-3.44M
1-Year Change
-92.45%
Ranking
Category
Stock Price
$0.09
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.58M to $4.88M, a decrease of -99.43%. That is a compound annual growth rate of -52.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 5.40M | -97.10% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mustang Bio | 6.79M |
| Moleculin Biotech | 6.56M |
| Immuron | 6.46M |
| Liminatus Pharma | 6.38M |
| Cyclerion Therapeutics | 5.83M |
| Psyence Biomedical | 5.73M |
| XTL Biopharmaceuticals | 5.49M |
| Lunai Bioworks | 5.13M |